Skip to main content
. 2018 Dec 11;18:316. doi: 10.1186/s12886-018-0978-9

Fig. 1.

Fig. 1

Hexagonal shaped single layer human endothelial corneal cells of donor corneas before (a, c, e, g) and after (b, d, f, h) incubation with 250 μg/ml ranibizumab (Lucentis®) or bevacizumab (Avastin®) at indicated magnifications. No statistical significant difference between before and after could be detected